Paid Clinical Trials for Metastatic Prostate Cancer

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing all 20 results

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

by CTG

in Prostate Cancer (Adenocarcinoma), Metastatic Prostate Cancer

Other

Maryland

Deadline:

03/30/2032

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

by CTG

in Prostate Cancer, Prostate Adenocarcinoma, Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Neoplasm

Other

New Jersey

Deadline:

07/01/2026

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

by CTG

in Prostate Cancer, Metastatic Prostate Cancer, Non-metastatic Prostate Cancer

Other

Massachusetts

Deadline:

06/01/2026

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

by CTG

in Metastatic Prostate Cancer

Other

Arkansas

Deadline:

01/18/2029

7-Days Water-Only Fasting Trial in Prostate Cancer

by CTG

in Metastatic Prostate Cancer

Other

Maryland

Deadline:

06/03/2026

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

by CTG

in Metastatic Prostate Cancer

Other

California

Deadline:

09/01/2026

Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

by CTG

in Metastatic Castration-Resistant Prostate Cancer, Metastatic Prostate Cancer

Other

Massachusetts

Deadline:

09/30/2026

A Study of Tarlatamab for People With Prostate Cancer

by CTG

in Metastatic Prostate Cancer

Other

New Jersey

Deadline:

08/31/2027

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

by CTG

in Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Prostatic Neoplasms, Metastatic Prostate Cancer

Other

Maryland

Deadline:

02/06/2028

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

by CTG

in Metastatic Prostate Cancer

Other

Colorado

Deadline:

08/31/2027

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

by CTG

in Metastatic Prostate Cancer, Advanced Prostate Cancer

Other

Arizona

Deadline:

06/30/2027

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

by CTG

in Prostate Cancer, Metastatic Prostate Carcinoma, Metastatic Prostate Cancer

Other

Massachusetts

Deadline:

02/28/2027

LuCarbo – a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

by CTG

in Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Prostate Cancer

Other

Massachusetts

Deadline:

07/19/2026

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

by CTG

in Prostate Cancer, Metastatic Prostate Cancer, Androgen Deprivation Therapy

Other

Utah

Deadline:

12/01/2029

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

by CTG

in Metastatic Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Hormone Sensitive Prostate Cancer

Other

Massachusetts

Deadline:

06/20/2027

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

by CTG

in Metastatic Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma

Other

Massachusetts

Deadline:

09/01/2028

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

by CTG

in Metastatic Prostate Cancer

Other

Utah

Deadline:

11/30/2028

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

by CTG

in Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Metastatic Prostate Cancer, Cancer Of Prostate

Other

Maryland

Deadline:

12/31/2030

Study of ORIC-944 in Patients with Metastatic Prostate Cancer

by CTG

in Metastatic Prostate Cancer

Other

Florida

Deadline:

09/01/2026

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL – GAP4)

by CTG

in Metastatic Prostate Cancer

Other

California

Deadline:

10/01/2026